Rapid Dose Therapeutics Corp
CNSX:DOSE
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
R
|
Rapid Dose Therapeutics Corp
CNSX:DOSE
|
18.6m CAD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.8B USD |
Loading...
|
|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
27.2B USD |
Loading...
|
|
| JP |
|
Terumo Corp
TSE:4543
|
3T JPY |
Loading...
|
|
| US |
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
17.5B USD |
Loading...
|
|
| US |
|
Insulet Corp
NASDAQ:PODD
|
17.2B USD |
Loading...
|
|
| US |
A
|
ABIOMED Inc
LSE:0H7S
|
17.2B USD |
Loading...
|
|
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
16.6B USD |
Loading...
|
|
| NZ |
|
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
|
23.4B NZD |
Loading...
|
|
| US |
|
Penumbra Inc
NYSE:PEN
|
13.4B USD |
Loading...
|
|
| US |
|
Shockwave Medical Inc
F:36M
|
11.3B EUR |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Rapid Dose Therapeutics Corp
Glance View
Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Rapid Dose Therapeutics Corp is 51.9%, which is below its 3-year median of 56.6%.
Over the last 3 years, Rapid Dose Therapeutics Corp’s Gross Margin has decreased from 72.8% to 51.9%. During this period, it reached a low of 51.9% on Oct 1, 2025 and a high of 72.8% on Jul 31, 2022.
